- Article
Responses to the Selective Bruton’s Tyrosine Kinase (BTK) Inhibitor Tirabrutinib (ONO/GS-4059) in Diffuse Large B-cell Lymphoma Cell Lines
- Ryohei Kozaki,
- Meike Vogler,
- Harriet S. Walter,
- Sandrine Jayne,
- David Dinsdale,
- Reiner Siebert,
- Martin J.S. Dyer and
- Toshio Yoshizawa
Bruton’s tyrosine kinase (BTK) is a key regulator of the B-cell receptor signaling pathway, and aberrant B-cell receptor (BCR) signaling has been implicated in the survival of malignant B-cells. However, responses of the diffuse large B-cell lymphoma...

